Wednesday, November 15, 2017 10:15 PM ET
Insider Makes Significant Stock buy in Immunomedics (IMMU) Shares Breaks Selling Trend of Last 90 Days
One Immunomedics insider — Dr Behzad Aghazadeh, 10% Owner and Director — today, acquired 1,325,000 shares having a market value of approximately $13,868,250, as revealed in a form 4 document filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 200,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net purchases of 1,125,000 shares and have averaged 508,333 shares per transaction over this time period.
Immunomedics insider trading represents a higher number of buy/sell transactions than for the 186 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 200 buy/sell trades during this period for an average of 1.1 transactions per company. The number of shares per buy/sell trade for Immunomedics insiders was also higher. Within the peer group there were 22,481,651 shares purchased and 31,895,627 shares sold with company insiders having sold 47,070 shares on average.
The data used in evaluating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.